Regeneron Pharmaceuticals REGN
NASDAQ REGN
$790.74 -5.60 (-0.70%)
At close: Oct 16, 2026 · 4:00 PM EDT

Regeneron Pharmaceuticals (REGN) Shares Outstanding (Diluted) (2010 - 2026)

Updated

Regeneron Pharmaceuticals (REGN) recorded Shares Outstanding (Diluted) of 106 million in Q2 2026, down 2.4% from 108.6 million a year earlier and down 1.6% from the prior quarter.

Analysis

Regeneron Pharmaceuticals (REGN) Shares Outstanding (Diluted) (2010 - 2026) Analysis & Trends

For FY2025, Regeneron Pharmaceuticals reported Shares Outstanding (Diluted) of 108.6 million, down 5.6% from FY2024.

  • Annual Shares Outstanding (Diluted) has a five-year compound annual growth rate of -1.2% (FY2020 to FY2025).
  • Across earlier years, Shares Outstanding (Diluted) came in at 115.1 million in FY2024 (+1.2%), 113.7 million in FY2023 (+0.2%), 113.5 million in FY2022 (+1.2%) and 112.2 million in FY2021 (-2.5%).
  • The Q2 2026 figure is the lowest quarterly Shares Outstanding (Diluted) since Q4 2011.
  • On a year-over-year basis, Shares Outstanding (Diluted) has declined for six consecutive quarters, with an average decline of 3.1% over the last eight quarters.
  • Peak year-over-year performance for Shares Outstanding (Diluted) in the last five years was growth of 2.9% in Q2 2022, against a decline of 7.7% in Q3 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at 107.7 million (Q1 2026), 108.6 million (Q4 2025) and 107.2 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Dil.) (Qtr)
1 Eli Lilly 1,122.91 Bn 1,091.50 Bn 19.71 Bn 893.70 Mn
2 Johnson & Johnson 615.09 Bn 533.62 Bn 17.26 Bn 2.44 Bn
3 AbbVie 504.75 Bn 477.86 Bn 12.70 Bn 1.77 Bn
4 Merck 360.18 Bn 314.55 Bn 12.21 Bn 2.47 Bn
5 Novartis Ag 292.05 Bn 256.04 Bn 11.24 Bn 1.96 Bn
6 Astrazeneca 256.09 Bn 229.78 Bn 12.86 Bn 1.56 Bn
7 Amgen 233.63 Bn 189.02 Bn 7.24 Bn 544.00 Mn
8 Gilead Sciences 194.49 Bn 168.69 Bn 6.22 Bn 1.24 Bn
9 Pfizer 168.35 Bn 114.99 Bn 10.94 Bn 5.70 Bn
10 Regeneron Pharmaceuticals 81.27 Bn 47.47 Bn 3.71 Bn 106.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 106.00 Mn
Mar 31, 2026 107.70 Mn
Dec 31, 2025 108.60 Mn
Sep 30, 2025 107.20 Mn
Jun 30, 2025 108.60 Mn
Mar 31, 2025 111.20 Mn
Dec 31, 2024 115.10 Mn
Sep 30, 2024 116.20 Mn
Jun 30, 2024 115.40 Mn
Mar 31, 2024 115.10 Mn
Dec 31, 2023 113.70 Mn
Sep 30, 2023 113.40 Mn
Jun 30, 2023 113.90 Mn
Mar 31, 2023 114.00 Mn
Dec 31, 2022 113.50 Mn
Sep 30, 2022 112.80 Mn
Jun 30, 2022 114.00 Mn
Mar 31, 2022 113.10 Mn
Dec 31, 2021 112.20 Mn
Sep 30, 2021 113.90 Mn
API Access

Regeneron Pharmaceuticals Shares Outstanding (Diluted) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=REGN&period=max&api_key=YOUR_API_KEY